Literature DB >> 36033431

Treatments for obesity in the context of nonalcoholic steatohepatitis and mental health.

Aadi Sharma1, Somaya Albhaisi2, Arun J Sanyal3.   

Abstract

Content available: Audio Recording.
© 2022 American Association for the Study of Liver Diseases.

Entities:  

Year:  2022        PMID： 36033431      PMCID： PMC9405488          DOI： 10.1002/cld.1219

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  24 in total

Review 1.  Substance use after bariatric surgery: A review.

Authors:  Linlin Li; Li-Tzy Wu
Journal:  J Psychiatr Res       Date:  2016-01-22       Impact factor: 4.791

2.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Authors:  Steven P Marso; Stephen C Bain; Agostino Consoli; Freddy G Eliaschewitz; Esteban Jódar; Lawrence A Leiter; Ildiko Lingvay; Julio Rosenstock; Jochen Seufert; Mark L Warren; Vincent Woo; Oluf Hansen; Anders G Holst; Jonas Pettersson; Tina Vilsbøll
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

3.  Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis.

Authors:  Daniel Castaneda; Violeta B Popov; Praneet Wander; Christopher C Thompson
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

4.  Obesity Therapy: How and Why?

Authors:  Sara Paccosi; Barbara Cresci; Laura Pala; Carlo Maria Rotella; Astrid Parenti
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

5.  Exploratory randomised controlled trial of a mindfulness-based weight loss intervention for women.

Authors:  Katy Tapper; Christine Shaw; Joanne Ilsley; Andrew J Hill; Frank W Bond; Laurence Moore
Journal:  Appetite       Date:  2008-12-03       Impact factor: 3.868

6.  Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

Authors:  Arne Astrup; Stephan Rössner; Luc Van Gaal; Aila Rissanen; Leo Niskanen; Mazin Al Hakim; Jesper Madsen; Mads F Rasmussen; Michael E J Lean
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

7.  Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.

Authors:  Mohammad Shadab Siddiqui; Salvatore Carbone; Robert Vincent; Samarth Patel; Carolyn Driscoll; Francesco S Celi; Hayley Billingsley; Brando Rotelli; Binu John; Nicola Potere; Michele Viscusi; Veronica Adiletta; Arun J Sanyal; Velimir A Luketic; Trevor Reichman; Chandra S Bhati
Journal:  Clin Gastroenterol Hepatol       Date:  2018-11-15       Impact factor: 11.382

8.  The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.

Authors:  Anna Secher; Jacob Jelsing; Arian F Baquero; Jacob Hecksher-Sørensen; Michael A Cowley; Louise S Dalbøge; Gitte Hansen; Kevin L Grove; Charles Pyke; Kirsten Raun; Lauge Schäffer; Mads Tang-Christensen; Saurabh Verma; Brent M Witgen; Niels Vrang; Lotte Bjerre Knudsen
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

9.  A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.

Authors:  Philip N Newsome; Kristine Buchholtz; Kenneth Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun J Sanyal; Anne-Sophie Sejling; Stephen A Harrison
Journal:  N Engl J Med       Date:  2020-11-13       Impact factor: 91.245

Review 10.  Comprehensive Review of Current and Upcoming Anti-Obesity Drugs.

Authors:  Jang Won Son; Sungrae Kim
Journal:  Diabetes Metab J       Date:  2020-12-23       Impact factor: 5.376
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.